Cynosure Acquire & Launch MyEllevate, The Innovative Minimally Invasive Surgical Suture System

By Cynosure UK Ltd. / 28 Mar 2022

London, UK, 28th March 2022. Cynosure announced that it has acquired the MyEllevate® Surgical Suture System and is thrilled to be launching in the UK from late March 2022, expanding the Company's best-in-class portfolio.

Highly committed to delivering the latest innovations to support healthcare professionals, and aid in answering patients rising demands for surgical results at a minimally invasive level, Cynosure is proud to be able to offer a discreet approach to the neck and jawline area.

Harnessing the power of the patented ICLED® light guided suture system, MyEllevate allows practitioners to easily place a suture support system without incisions, helping to define and enhance the jawline, elevate the sub-dermis and underlying muscle with rapid recovery and a lasting outcome.

Cynosure will officially launch MyEllevate into the UK aesthetic surgical market at an exclusive cadaver training event on 24th March, hosted by Dr. Gregory Mueller, MD, FACS Board Certified Plastic Surgeon and Inventor of the MyEllevate System.

"MyEllevate broadens Cynosure's already extensive surgical product portfolio, enabling us to offer this ground-breaking procedure in combination with other energy-based skin tightening technologies for optimal, long-lasting results," said Todd Tillemans, Chief Executive Officer of Cynosure. "Also known as the Zoom Lift, MyEllevate has gained popularity recently as more patients look for minimally invasive solutions to improve their appearance in today's world of virtual meetings. It's a cutting-edge treatment, and we're thrilled to be able to offer this highly sought-after procedure to selected UK customers so that they can bring out the Beautiful Energy in everyone."

As part of their ongoing commitment to quality and patient safety, Cynosure will only be making the MyEllevate procedure available to plastic surgeons in the UK, and this specialised launch training event at Guys’ & St Thomas’ Hospital will enable selected expert plastic surgeons to understand the critical patient indications and selection process, alongside the surgical technique from the device founder himself.

This acquisition comes as part of a continued effort from Cynosure, to provide a portfolio of devices that sit at the forefront of cutting-edge technology.

About MyEllevate®

MyEllevate, performed with the ICLED light guided suture system, is the first and only patented light guided technology for use in soft tissue approximation and the elevation of sub dermis and underlying muscle. This one-time use disposable surgical kit enables the placement of a suture support system through a series of guided needle punctures for a less invasive approach.

"As procedures like neck and face lifts continue to decline in popularity due to their invasiveness and extensive recovery time, patients are seeking new and innovative options” said Dr. Mueller. “With Cynosure's global reach and leadership, we'll have the opportunity to enter new markets and expand access to MyEllevate and its long-lasting facial rejuvenation results."

MyEllevate can be performed under local anaesthesia and can be used as a stand-alone procedure or in combination with other treatments such as Potenza, TempSure® Surgical or SmartLipo® laser lipolysis treatments and energy-based skin tightening technologies.

About Cynosure

Cynosure is the global leader in medical aesthetics and develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists, and other medical practitioners to perform non-invasive and minimally invasive procedures for skin revitalization, hair removal, body contouring, women's health, treat vascular and benign pigmented lesions, remove multi-coloured tattoos, reduce fat through laser lipolysis, and reduce cellulite. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light, and RF technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio, and Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Thailand, Japan, and Korea, and through international distributors in approximately 130 other countries.

For corporate or product information, visit Cynosure's website at

Media Contacts:

Fiona Comport, Senior Manager Marketing, Europe North - Cynosure

Rachel Taylor, Account Director, Kendrick PR